Algo version: 0.98b
AMYT is listed at the NASDAQ Exchange
AMYT [AMYT]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is AMYT stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Amryt Pharma plc 10 years ago, but if you had invested on Tuesday 31st of December 2019 when the price was $7.95, you would have made a profit of $6.75 per share or 84.91%

Yes, the average daily trading liquidity for Amryt Pharma plc is $7.57 million. You should therefore be able to get in and out of your positions relatively fast.

Amryt Pharma plc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.08, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Amryt Pharma plc to be high [0.75 out of 1]